UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 23, 2017

 

 

M IRATI T HERAPEUTICS , I NC .

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-35921   46-2693615
(State of incorporation)  

(Commission

File No.)

 

(IRS Employer

Identification No.)

9393 Towne Centre Drive, Suite 200

San Diego, California 92121

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (858) 332-3410

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 1.01 Entry into a Material Definitive Agreement

On March 23, the Company entered into a First Amendment to Lease Agreement (the “Amendment”) with ARE-SD Region No. 20 (the “Landlord”) to amend the Lease Agreement (the “Original Lease”), dated June 24, 2014, between the Company and Landlord. The Amendment extends the term of the Original Lease for one year through January 31, 2019. All other terms and covenants from the Original Lease remain unchanged.

A copy of the Amendment is filed as Exhibit 10.1 to this report and the description of the terms of the Amendment is qualified in its entirety by reference to such exhibit.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
No.

  

Description

10.1    First Amendment to Lease to 9393 Towne Centre Drive, dated March 23, 2017.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 27, 2017

   

M IRATI T HERAPEUTICS , I NC .

   

By:

 

/s/ Jamie A. Donadio

     

Jamie A. Donadio

     

Senior Vice President and Chief Financial Officer

INDEX TO EXHIBITS

 

Exhibit
No.

  

Description

10.1    First Amendment to Lease to 9393 Towne Centre Drive, dated March 23, 2017.
Mirati Therapeutics (NASDAQ:MRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Mirati Therapeutics Charts.
Mirati Therapeutics (NASDAQ:MRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Mirati Therapeutics Charts.